These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19264510)

  • 1. Biologicals.
    Petricciani J
    Biologicals; 2009 Aug; 37(4):270. PubMed ID: 19264510
    [No Abstract]   [Full Text] [Related]  

  • 2. Acceptability of cell substrates for production of biologicals. Report of a WHO Study Group on Biologicals.
    World Health Organ Tech Rep Ser; 1987; 747():1-29. PubMed ID: 3107222
    [No Abstract]   [Full Text] [Related]  

  • 3. A collaborative study on DNA quantitation in biological products.
    Robertson JS; Heath AB
    Biologicals; 1995 Sep; 23(3):199-205. PubMed ID: 8527118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings of the 15th International Symposium on Pharmaceutical and Biomedical Analysis. May 2-6, 2004. Florence, Italy.
    J Pharm Biomed Anal; 2005 Apr; 37(5):829-1183. PubMed ID: 15862655
    [No Abstract]   [Full Text] [Related]  

  • 5. Status of WHO concerning continuous cell lines as substrates for the production of biologicals.
    Grachev V; Magrath D
    Dev Biol Stand; 1989; 70():215-9. PubMed ID: 2759349
    [No Abstract]   [Full Text] [Related]  

  • 6. WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals (requirements for biological substances No 50).
    Dev Biol Stand; 1998; 93():141-71. PubMed ID: 9737395
    [No Abstract]   [Full Text] [Related]  

  • 7. [Analytical standards for the evaluation of biological and pharmaceutical products].
    Pacheco MG
    Rev Invest Salud Publica; 1970; 30(4):316-22. PubMed ID: 5516708
    [No Abstract]   [Full Text] [Related]  

  • 8. WHO Expert Committee on Biological Standardization.
    World Health Organ Tech Rep Ser; 1994; 840():1-218. PubMed ID: 8203143
    [No Abstract]   [Full Text] [Related]  

  • 9. WHO's influence on the control of biologicals.
    Mathews AG
    WHO Chron; 1969 Jan; 23(1):3-15. PubMed ID: 5764614
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of the individual and the community in the research, development, and use of biologicals.
    Cockburn WC
    WHO Chron; 1978 Jul; 32(7):283-5. PubMed ID: 695544
    [No Abstract]   [Full Text] [Related]  

  • 11. WHO Study Group on cell substrates for production of biologicals, Geneva, Switzerland, 11-12 June 2007.
    Knezevic I; Stacey G; Petricciani J;
    Biologicals; 2008 May; 36(3):203-11. PubMed ID: 18218325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing role of formulation in biologics drug development.
    Saylor T
    Drug Discov Today; 2014 Aug; 19(8):1031-2. PubMed ID: 24815923
    [No Abstract]   [Full Text] [Related]  

  • 13. Simple and efficient method for the preparation of nuclear extracts.
    Fei Y; Matragoon S; Liou GI
    Biotechniques; 1995 Jun; 18(6):984-7. PubMed ID: 7546723
    [No Abstract]   [Full Text] [Related]  

  • 14. Using nuclear magnetic resonance spectroscopy to characterize biologicals.
    Freedberg DI
    Dev Biol (Basel); 2005; 122():77-83. PubMed ID: 16375252
    [No Abstract]   [Full Text] [Related]  

  • 15. Bad blood and biologicals: the need for new radiopharmaceutical source materials.
    Perkins AC; Frier M
    Nucl Med Commun; 1999 Jan; 20(1):1-3. PubMed ID: 9949406
    [No Abstract]   [Full Text] [Related]  

  • 16. Eleventh meeting on Recent Developments in Pharmaceutical Analysis (RDPA 2005). Rimini (Italy), September 25-28, 2005.
    Bertucci C; Cavrini V
    J Sep Sci; 2006 Jan; 29(1):182. PubMed ID: 16485725
    [No Abstract]   [Full Text] [Related]  

  • 17. Web alert. The chemistry of biological products.
    Cavalla D
    Curr Opin Drug Discov Devel; 2001 Mar; 4(2):168-9. PubMed ID: 11378955
    [No Abstract]   [Full Text] [Related]  

  • 18. An introduction to the special issue on pharmaceuticals, drug discovery and natural products.
    Frampton CS
    Acta Crystallogr C; 2013 Nov; 69(Pt 11):1205-6. PubMed ID: 24192158
    [No Abstract]   [Full Text] [Related]  

  • 19. Who Expert Committee on Biological Standardization.
    World Health Organization
    World Health Organ Tech Rep Ser; 2005; 927():1-154. PubMed ID: 16454167
    [No Abstract]   [Full Text] [Related]  

  • 20. A Bayesian Approach to Residual Host Cell DNA Safety Assessment.
    Yang H; Zhang J
    PDA J Pharm Sci Technol; 2016; 70(2):157-62. PubMed ID: 26797975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.